Dual GIP/GLP-1 Receptor Agonist2.5 mg

2.5 mg Tirzepatide Dosage Calculator

Calculate the exact units for your 2.5 mg tirzepatide starting dose across all available vial concentrations.

050100

How many units is 2.5 mg of Tirzepatide at 5 mg/mL?

Draw

50units

0.50 mL on a U-100 insulin syringe

2.5 mg ÷ 5 mg/mL × 100 = 50 units

For educational purposes only. Always follow your provider's instructions.

Quick Reference Table

All dose × concentration combinations

Dose5 mg/mL10 mg/mL15 mg/mL25 mg/mL30 mg/mL60 mg/mL90 mg/mL100 mg/mL
2.5 mg502516.7108.34.22.82.5
5 mg100*5033.32016.78.35.65
7.5 mg150*75*50302512.58.37.5
10 mg200*100*66.7*4033.316.711.110
12.5 mg250*125*83.3*5041.720.813.912.5
15 mg300*150*100*60*502516.715

Values in U-100 insulin syringe units

* Exceeds 50 units (0.5 mL) — may require splitting into two injections

There's an easier way

Tired of calculating doses?

We handle everything — the prescription, the right dose, and shipping straight to your door. No math, no hassle.

Get Started

2-min quiz · Free consultation · No commitment

About the 2.5 mg Dose

The 2.5 mg dose is the starting dose for both Mounjaro and Zepbound during weeks 1 through 4. This introductory dose allows patients to acclimate to tirzepatide's dual GIP and GLP-1 receptor agonist mechanism. Most patients tolerate this dose well with mild or no gastrointestinal side effects before escalating to 5 mg.

Frequently Asked Questions

In a 10 mg/mL vial, 2.5 mg tirzepatide equals 25 units. The math is (2.5 / 10) x 100 = 25 units. In a 5 mg/mL vial it would be 50 units, and in a 25 mg/mL vial it would be 10 units.

The standard titration schedule keeps patients at 2.5 mg for the first 4 weeks. After this initial period, your provider will typically increase your dose to 5 mg. The 2.5 mg dose is not intended as a maintenance dose — it exists solely to help your body adjust to the medication.

Some patients do experience modest weight loss at 2.5 mg, but significant results typically occur at higher doses. Clinical trials showed the most substantial weight loss at doses of 10 mg and above. The primary purpose of the 2.5 mg dose is to allow your body to adjust to tirzepatide with minimal side effects.

Tirzepatide starts at 2.5 mg while semaglutide starts at 0.25 mg, but these are not directly comparable because the medications have different potencies and mechanisms. Tirzepatide acts on both GIP and GLP-1 receptors, while semaglutide targets only GLP-1. Both starting doses are calibrated to introduce their respective medications gradually.

Other Tirzepatide Doses

Related Pages

Ready to Get Started?

Take our 2-minute quiz to see if you qualify for GLP-1 treatment.

Start Quiz

Free consultation. No commitment.